Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Gold Fields
GFI
$36.5B
| $2.28M | ﹤0.01% |
209,507
+127,542
| +156% | +$1.68M |
|
1777
FB Financial Corp
FBK
$3.04B
| $2.27M | ﹤0.01% |
80,111
-459
| -0.6% | -$14.2K |
|
1778
Rush Enterprises Class A
RUSHA
$6.27B
| $2.26M | ﹤0.01% |
55,445
-15,477
| -22% | -$640K |
|
|
SWTX
1779
DELISTED
SpringWorks Therapeutics
SWTX
| $2.26M | ﹤0.01% |
97,916
-23,844
| -20% | -$652K |
|
1780
Caleres
CAL
$476M
| $2.26M | ﹤0.01% |
78,486
-6,927
| -8% | -$184K |
|
1781
PUT
Nokia
NOK
$52.3B
| $2.25M | ﹤0.01% |
+602,000
| New | +$2.37M |
|
|
GHL
1782
DELISTED
Greenhill & Co., Inc.
GHL
| $2.25M | ﹤0.01% |
152,002
+148,546
| +4,298% | +$2.19M |
|
1783
Grand Canyon Education
LOPE
$3.97B
| $2.25M | ﹤0.01% |
19,245
-10,973
| -36% | -$1.22M |
|
1784
OFG Bancorp
OFG
$2.21B
| $2.25M | ﹤0.01% |
75,312
-9,714
| -11% | -$296K |
|
1785
OneMain Financial
OMF
$7.43B
| $2.24M | ﹤0.01% |
55,854
-33,229
| -37% | -$1.42M |
|
1786
Amkor Technology
AMKR
$13.7B
| $2.24M | ﹤0.01% |
99,078
-24,781
| -20% | -$653K |
|
1787
NewMarket
NEU
$8.19B
| $2.24M | ﹤0.01% |
4,918
-3,837
| -44% | -$1.73M |
|
1788
Essential Properties Realty Trust
EPRT
$6.61B
| $2.22M | ﹤0.01% |
102,783
-8,279
| -7% | -$197K |
|
1789
Zentalis Pharmaceuticals
ZNTL
$297M
| $2.22M | ﹤0.01% |
110,817
-101,598
| -48% | -$2.58M |
|
1790
Calix
CALX
$2.41B
| $2.22M | ﹤0.01% |
48,456
+1,829
| +4% | +$82.8K |
|
1791
Jackson Financial
JXN
$8.82B
| $2.22M | ﹤0.01% |
58,105
-648
| -1% | -$22.6K |
|
1792
CAE Inc. Common Shares
CAE
$8.7B
| $2.22M | ﹤0.01% |
95,080
+83,952
| +754% | +$1.94M |
|
|
PRFT
1793
PUT
DELISTED
Perficient Inc
PRFT
| $2.21M | ﹤0.01% |
+38,200
| New | +$2.62M |
|
1794
Sabra Healthcare REIT
SBRA
$5.36B
| $2.21M | ﹤0.01% |
158,210
-710,495
| -82% | -$9.09M |
|
1795
MasterBrand
MBC
$1.9B
| $2.2M | ﹤0.01% |
180,687
+12,403
| +7% | +$152K |
|
1796
ESAB
ESAB
$5.81B
| $2.19M | ﹤0.01% |
31,211
-175
| -0.6% | -$12.2K |
|
|
SVC
1797
Service Properties Trust
SVC
$1.08B
| $2.19M | ﹤0.01% |
56,888
-77,658
| -58% | -$3.23M |
|
1798
B2Gold
BTG
$6.62B
| $2.19M | ﹤0.01% |
756,488
-247,006
| -25% | -$804K |
|
1799
Herc Holdings
HRI
$5.73B
| $2.18M | ﹤0.01% |
18,366
-554
| -3% | -$72.3K |
|
1800
Progyny
PGNY
$2.25B
| $2.18M | ﹤0.01% |
64,107
+2,016
| +3% | +$76.1K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.